These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 31727273)
21. Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro. Jin C; Bai L; Wu H; Tian F; Guo G Biomaterials; 2007 Sep; 28(25):3724-30. PubMed ID: 17509678 [TBL] [Abstract][Full Text] [Related]
22. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity. Oya N; Shibamoto Y; Sasai K; Shibata T; Murata R; Takagi T; Iwai H; Suzuki T; Abe M Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):119-27. PubMed ID: 7642409 [TBL] [Abstract][Full Text] [Related]
24. KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics. Sasai K; Shibamoto Y; Takahashi M; Zhou L; Hori H; Nagasawa H; Shibata T; Inayama S; Abe M Cancer Chemother Pharmacol; 1990; 26(2):112-6. PubMed ID: 2140730 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumor cell line high in intracellular glutathione. DeGraff WG; Russo A; Gamson J; Mitchell JB Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1021-4. PubMed ID: 2522917 [TBL] [Abstract][Full Text] [Related]
26. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170). Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527 [TBL] [Abstract][Full Text] [Related]
27. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II). Herman TS; Teicher BA; Pfeffer MR; Khandekar V; Chapnick RM; Kalick GS; Rabow A Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699 [TBL] [Abstract][Full Text] [Related]
28. The hypoxic cytotoxin SR 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenografts. Wilder RB; McGann JK; Sutherland WR; Waller EK; Minchinton AI; Goris ML; Knox SJ Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):119-26. PubMed ID: 8270432 [TBL] [Abstract][Full Text] [Related]
29. Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole). Newman HF; Bleehen NM; Ward R; Workman P Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):677-84. PubMed ID: 2843488 [TBL] [Abstract][Full Text] [Related]
30. Comparison of radiosensitizing effect of KU-2285 and SR-2508 at low drug concentrations and doses. Shibata T; Shibamoto Y; Oya N; Sasai K; Murata R; Ishigaki T; Abe M Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):587-90. PubMed ID: 8005820 [TBL] [Abstract][Full Text] [Related]
31. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170. Sasai K; Shibamoto Y; Takahashi M; Abe M; Wang J; Zhou L; Nishimoto S; Kagiya T Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634 [TBL] [Abstract][Full Text] [Related]
32. Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation. Teicher BA; Herman TS; Holden SA; Jones SM J Natl Cancer Inst; 1989 Jun; 81(12):929-34. PubMed ID: 2525198 [TBL] [Abstract][Full Text] [Related]
33. Oncogenic transforming potential of etanidazole. Hall EJ; Hei TK Int J Radiat Oncol Biol Phys; 1992; 22(4):743-5. PubMed ID: 1531978 [TBL] [Abstract][Full Text] [Related]
34. Effect of BSO and etanidazole on neurofilament degradation in neonatal rat spinal cord cultures. Palayoor ST; Bump EA; Saroff DM; Delfs JR; Geula C; Menton-Brennan L; Hurwitz SJ; Coleman CN; Stevenson MA Br J Cancer Suppl; 1996 Jul; 27():S117-21. PubMed ID: 8763862 [TBL] [Abstract][Full Text] [Related]
35. [Development of new hypoxic cell radiosensitizer in Japan]. Mori T; Murayama C Gan No Rinsho; 1988 Oct; 34(13):1869-74. PubMed ID: 2974089 [TBL] [Abstract][Full Text] [Related]
36. The radiosensitizing effects of hypoxic cell sensitizer on SCCVII tumors in mice evaluated by highly accurate colony formation assay assisted by microcomputer. Ono K; Akuta K; Masunaga S; Kinashi Y; Suzuki M Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Dec; 56(14):1066-70. PubMed ID: 9014470 [No Abstract] [Full Text] [Related]
37. Pharmacokinetics of fluorinated 2-nitroimidazole hypoxic cell radiosensitizers in murine peripheral nervous tissue. Sasai K; Iwai H; Yoshizawa T; Nishimoto S; Shibamoto Y; Kitakabu Y; Oya N; Takahashi M; Abe M Int J Radiat Biol; 1992 Aug; 62(2):221-7. PubMed ID: 1355516 [TBL] [Abstract][Full Text] [Related]
38. Hyperthermia-triggered release of hypoxic cell radiosensitizers from temperature-sensitive liposomes improves radiotherapy efficacy in vitro. Sadeghi N; Kok RJ; Bos C; Zandvliet M; Geerts WJC; Storm G; Moonen CTW; Lammers T; Deckers R Nanotechnology; 2019 Jun; 30(26):264001. PubMed ID: 30836341 [TBL] [Abstract][Full Text] [Related]
39. Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer. Brown JM; Diehn M; Loo BW Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):323-7. PubMed ID: 20832663 [TBL] [Abstract][Full Text] [Related]
40. Sensitization of Chinese hamster ovary cells to melphalan by etanidazole under intermittent hypoxia. Bump EA; Coleman CN; Cerce BA; McGinnis DJ Int J Radiat Oncol Biol Phys; 1992; 22(4):731-5. PubMed ID: 1531977 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]